ViroGates announces that the development and regulatory approval of the suPARnostic® TurbiLatex product for Roche Diagnostics cobas c500 and c700 series has been completed.

ViroGates announces that the development and regulatory approval of the suPARnostic® TurbiLatex product for Roche Diagnostics cobas c502 has been completed.

Meet us at DINK, Deutscher Interdisziplinärer Notfallmedizin Kongress on March 21-22 in Koblenz, Germany and hear about suPARnostic®

Meet us at Emergency Conference SWEET on March 13-15 in Stockholm, Sweden and hear about suPARnostic®